The updated development of blood-based biomarkers for Huntington’s disease

Huntington’s disease is a progressive neurodegenerative disease caused by mutation of the huntingtin (HTT) gene. The identification of mutation carriers before symptom onset provides an opportunity to intervene in the early stage of the disease course. Optimal biomarkers are of great value to reflec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sirui, Cheng, Yangfan, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873222/
https://www.ncbi.nlm.nih.gov/pubmed/36692635
http://dx.doi.org/10.1007/s00415-023-11572-x

Ejemplares similares

Ejemplares similares